Literature DB >> 15917504

Attitudes of Emergency Medical Service providers towards naloxone distribution programs.

Karin E Tobin1, Wade R Gaasch, Carla Clarke, Ellen MacKenzie, Carl A Latkin.   

Abstract

Training and distributing naloxone to drug users is a promising method for reducing deaths associated with heroin overdose. Emergency Medical Service (EMS) providers have experience responding to overdose, administering naloxone, and performing clinical management of the patient. Little is known about the attitudes of EMS providers toward training drug users to use naloxone. We conducted an anonymous survey of 327 EMS providers to assess their attitudes toward a pilot naloxone program. Of 176 who completed the survey, the majority were male (79%) and Caucasian (75%). The average number of years working as an EMS provider was 7 (SD=6). Overall attitudes toward training drug users to administer naloxone were negative with 56% responding that this training would not be effective in reducing overdose deaths. Differences in attitudes did not vary by gender, level of training, or age. Providers with greater number of years working in EMS were more likely to view naloxone trainings as effective in reducing overdose death. Provider concerns included drug users' inability to properly administer the drug, program condoning and promoting drug use, and unsafe disposal of used needles. Incorporating information about substance abuse and harm reduction approaches in continuing education classes may improve the attitudes of provider toward naloxone training programs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917504      PMCID: PMC3456561          DOI: 10.1093/jurban/jti052

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  8 in total

1.  Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes.

Authors:  K Dettmer; B Saunders; J Strang
Journal:  BMJ       Date:  2001-04-14

2.  Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.

Authors:  J Strang; B Powis; D Best; L Vingoe; P Griffiths; C Taylor; S Welch; M Gossop
Journal:  Addiction       Date:  1999-02       Impact factor: 6.526

Review 3.  The distribution of naloxone to heroin users.

Authors:  S Darke; W Hall
Journal:  Addiction       Date:  1997-09       Impact factor: 6.526

4.  Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study.

Authors:  E Oppenheimer; C Tobutt; C Taylor; T Andrew
Journal:  Addiction       Date:  1994-10       Impact factor: 6.526

5.  Retention in methadone maintenance and heroin addicts' risk of death.

Authors:  J R Caplehorn; M S Dalton; M C Cluff; A M Petrenas
Journal:  Addiction       Date:  1994-02       Impact factor: 6.526

6.  Morbidity associated with non-fatal heroin overdose.

Authors:  Matthew Warner-Smith; Shane Darke; Carolyn Day
Journal:  Addiction       Date:  2002-08       Impact factor: 6.526

7.  Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.

Authors:  Phillip O Coffin; Crystal Fuller; Liza Vadnai; Shannon Blaney; Sandro Galea; David Vlahov
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

8.  Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.

Authors:  Karen H Seal; Moher Downing; Alex H Kral; Shannon Singleton-Banks; Jon-Paul Hammond; Jennifer Lorvick; Dan Ciccarone; Brian R Edlin
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

  8 in total
  11 in total

1.  Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.

Authors:  Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

2.  Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Authors:  Leo Beletsky; Robin Ruthazer; Grace E Macalino; Josiah D Rich; Litjen Tan; Scott Burris
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

3.  Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Authors:  Ingrid A Binswanger; Stephen Koester; Shane R Mueller; Edward M Gardner; Kristin Goddard; Jason M Glanz
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

Review 4.  A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Authors:  Shane R Mueller; Alexander Y Walley; Susan L Calcaterra; Jason M Glanz; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

5.  A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.

Authors:  Hawraa Sameer Sajwani; Anna V Williams
Journal:  Harm Reduct J       Date:  2022-10-20

6.  Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Authors:  Debra Kerr; Paul Dietze; Anne-Maree Kelly; Damien Jolley
Journal:  J Urban Health       Date:  2008-03-18       Impact factor: 3.671

7.  Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users.

Authors:  Jermaine D Jones; Perrine Roux; Sharon Stancliff; William Matthews; Sandra D Comer
Journal:  Int J Drug Policy       Date:  2013-06-15

8.  Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.

Authors:  Traci C Green; Robert Heimer; Lauretta E Grau
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

9.  Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality.

Authors:  Daniel Kim; Kevin S Irwin; Kaveh Khoshnood
Journal:  Am J Public Health       Date:  2009-01-15       Impact factor: 9.308

10.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.